Skip to main content
Equibles

STATE STREET CORP

Position in SPTX — Seaport Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to SPTX Full portfolio

Position in SPTX

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$1,447,638
New position
Shares Held
66,650
first reported quarter
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 54 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 81% Shared 0% None 19%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. SPTX ranks #286 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SPTX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $1,447,638 66,650